0

200 mg Avelumab Injection

200 mg Avelumab Injection
200 mg Avelumab Injection
Product Description
We are a trusted name among the manufacturers of 200 mg Avelumab Injection in the market. It is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). 200 mg Avelumab Injection is approved under accelerated approval based on tumor response rate and duration of response.

Contact Us

4-B 1st Floor, Pusa Road, New Delhi, Delhi, 110060, India
Phone :+918045804069